Kinex Pharmaceuticals Secures $300,000 New Funding

  • Feed Type
  • Date
    12/23/2013
  • Company Name
    Kinex Pharmaceuticals
  • Mailing Address
    701 Ellicott Street Buffalo, NY 14203
  • Company Description
    Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.
  • Website
    http://www.kinexpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.